PRMT5 and B-cell non-Hodgkin lymphoma: Anti-proliferative and anti-apoptotic effects are observed in PRMT5-depleted B-cell lymphoma using antisense oligonucleotides through the alteration of splicing of genes involved in lymphomagenesis [77].